These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases. Zhao L; Johnson T; Liu D Stem Cell Res Ther; 2017 Jun; 8(1):125. PubMed ID: 28583178 [TBL] [Abstract][Full Text] [Related]
34. Circulating endothelial progenitor cells: Do they live up to their name? Madonna R; De Caterina R Vascul Pharmacol; 2015; 67-69():2-5. PubMed ID: 25869520 [TBL] [Abstract][Full Text] [Related]
35. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991 [TBL] [Abstract][Full Text] [Related]
36. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Marsboom G; Janssens S Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485 [TBL] [Abstract][Full Text] [Related]
38. Cell therapy for heart failure: the need for a new therapeutic strategy. Povsic TJ; O'Connor CM Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1107-26. PubMed ID: 20670189 [TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting. Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448 [TBL] [Abstract][Full Text] [Related]